Latest IR information
IR News
- 2024.11.20
- SymBio Presents Research Results Showing Potential Use of Intravenous Brincidofovir in Combination with Immune Checkpoint Inhibitors as a Therapy for Malignant Lymphoma at the 66th the American Society of Hematology Annual Meeting
- 2024.11.05
- Notice of Appointment of Executive Vice President, Corporate Officer and Global CMO
- 2024.10.31
- Summary of Consolidated Financial Statements for the First Nine Months of Fiscal Year Ending December 31, 2024 [Japanese GAAP]
- 2024.10.23
- SymBio presents data from Phase IIa clinical trial showing clinical efficacy of IV BCV in treating symptoms of adenovirus infection
- 2024.09.30
- SymBio Reaches Settlement Agreement in Patent Infringement Litigation Related to TREAKISYM